# A Comparative Study of ZG-801 and Placebo in Patients With Hyperkalemia

> **NCT04955678** · PHASE3 · COMPLETED · sponsor: **Zeria Pharmaceutical** · enrollment: 85 (actual)

## Conditions studied

- Hyperkalemia

## Interventions

- **DRUG:** Calcium, hydrolysed divinylbenzene-Me 2-fluoro-2-propenoate-1, 7-octadiene polymer sorbitol complexes
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04955678
- **Lead sponsor:** Zeria Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-03
- **Primary completion:** 2022-12-26
- **Final completion:** 2023-03-13
- **Target enrollment:** 85 (ACTUAL)
- **Last updated:** 2023-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04955678

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04955678, "A Comparative Study of ZG-801 and Placebo in Patients With Hyperkalemia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04955678. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*